mRNA – The Medical Revolution?

IAPCO Member: INTERPLAN, Germany

In the wake of the ongoing Corona pandemic and the search for promising measures to contain it, the topic of vaccination is currently at the centre of public attention. Since 2019, INTERPLAN has been proud to count among its clients some of the key players in the current debate, the companies BioNTech, CureVac and Moderna, and thus the alignment of the International mRNA Health Conference.

The highly exciting topic of mRNA technology, which has the potential to revolutionise medicine the way the iPhone revolutionised communication, was the focus of the annual meeting at the beginning of November 2020. The digital conference, which usually alternates between Berlin and Boston, provided a virtual yet no less imposing stage for leading experts to present and discuss cutting-edge research findings and recent experiences. Leading scientists and top virologists such as the internationally respected advisor to the U.S. government, Anthony Fauci, gave their contributions to the excellent quality and high relevance of the meeting. With the conference in full swing, the market maturity of BioNTech’s vaccine was announced, further boosting attention around the event. And more good news is in the pipeline, as CureVac also expects its vaccine to be approved by summer 2021.

INTERPLAN was happy to facilitate a lively exchange between speakers, around 700 attendees, and representatives from pharma and biotech companies by building a modern, user-friendly and stable conference platform that covered the stakeholder’s needs in a tailor-made manner.

“After the meeting is before the meeting, thus we are already looking forward to preparing the next event in November 2021 in Berlin, Germany - Let’s see what is new in the world of mRNA by then!”